CSPC Pharmaceutical Group (1093) Price & Analysis

Compare

13 Followers

1093 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$4.27 - HK$9.48

Previous CloseN/A

Volume61.16M

Average Volume (3M)239.74M

Market Cap

HK$94.18B

Enterprise ValueHK$76.71B

Total Cash (Recent Filing)HK$8.25B

Total Debt (Recent Filing)¥507.33M

Price to Earnings (P/E)20.5

Beta0.95

Next Earnings

Aug 20, 2025

EPS Estimate

0.13

Last Dividend Ex-Date

Jun 04, 2025

Dividend Yield2.44%

Share Statistics

EPS (TTM)0.14

Shares Outstanding11,518,252,000

10 Day Avg. Volume299,671,840

30 Day Avg. Volume239,742,693

Financial Highlights & Ratios

PEG Ratio-1.77

Price to Book (P/B)2.90

Price to Sales (P/S)0.00

P/FCF Ratio16.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$8.01

Price Target Upside-1.52% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering8

CSPC Pharmaceutical Group News

PremiumCompany Announcements

CSPC Pharmaceutical Group Partners with AstraZeneca for AI-Driven Drug Discovery

7d ago

PremiumCompany Announcements

CSPC Pharmaceutical Gains U.S. FDA Approval for Cancer Drug Trial

10d ago

PremiumCompany Announcements

CSPC Pharmaceutical’s Cobamamide Capsules Gain Approval in China

15d ago

PremiumCompany Announcements

CSPC’s JMT101 Receives Breakthrough Therapy Designation in China

18d ago

PremiumCompany Announcements

CSPC Pharmaceutical Group’s AGM Resolutions Passed Successfully

21d ago

PremiumCompany Announcements

CSPC Pharmaceutical Group Reports Q1 2025 Earnings

21d ago

PremiumCompany Announcements

CSPC Pharmaceutical Group in Talks for Major Licensing Deals

21d ago

PremiumCompany Announcements

CSPC Pharmaceutical Group Reports Decline in Q1 2025 Results Amid Industry Challenges

22d ago

See All HK:1093 News

See All News >

Bulls Say, Bears Say

Bulls Say

Out-licensing DealsCSPC Pharmaceutical is expected to engage in three large-scale out-licensing deals, each potentially exceeding US$5bn in value, which could significantly boost revenue.

Research And DevelopmentCSPC's strong research and development capabilities, supported by significant spending, have resulted in a rich pipeline of 40–50 assets with business development potential.

Bears Say

Price Cuts ImpactThe significant decline in net profit is attributed to margin erosion caused by large price cuts under the '3+N' Alliance provincial VBP program.

Profit WarningCSPC released profit warning for FY24, with management expecting net profit to decline by 26% due to weak finished drug sales.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

3.91%

Mutual Funds

― Other Institutional Investors

88.78% Public Companies and

Individual Investors

Detailed Ownership Overview >

1093 FAQ

What was CSPC Pharmaceutical Group ’s price range in the past 12 months?

CSPC Pharmaceutical Group lowest stock price was HK$4.27 and its highest was HK$9.48 in the past 12 months.

What is CSPC Pharmaceutical Group ’s market cap?

CSPC Pharmaceutical Group ’s market cap is HK$94.18B.

When is CSPC Pharmaceutical Group ’s upcoming earnings report date?

CSPC Pharmaceutical Group ’s upcoming earnings report date is Aug 20, 2025 which is in 61 days.

How were CSPC Pharmaceutical Group ’s earnings last quarter?

CSPC Pharmaceutical Group released its earnings results on May 29, 2025. The company reported HK$0.14 earnings per share for the quarter, beating the consensus estimate of HK$0.131 by HK$0.01.

Is CSPC Pharmaceutical Group overvalued?

According to Wall Street analysts CSPC Pharmaceutical Group ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does CSPC Pharmaceutical Group pay dividends?

CSPC Pharmaceutical Group pays a Semiannually dividend of HK$0.1 which represents an annual dividend yield of 2.44%. See more information on CSPC Pharmaceutical Group dividends here

What is CSPC Pharmaceutical Group ’s EPS estimate?

CSPC Pharmaceutical Group ’s EPS estimate is 0.13.

How many shares outstanding does CSPC Pharmaceutical Group have?

CSPC Pharmaceutical Group has 11,518,252,000 shares outstanding.

What happened to CSPC Pharmaceutical Group ’s price movement after its last earnings report?

CSPC Pharmaceutical Group reported an EPS of HK$0.14 in its last earnings report, beating expectations of HK$0.131. Following the earnings report the stock price went up 11.735%.

Which hedge fund is a major shareholder of CSPC Pharmaceutical Group ?

Currently, no hedge funds are holding shares in HK:1093

CSPC Pharmaceutical Group Stock Smart Score

Outperform

Fundamentals

Return on Equity

13.20%

Trailing 12-Months

Asset Growth

-6.81%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

CSPC Pharmaceutical Group

CSPC Pharmaceutical Group (1093) is a leading pharmaceutical company based in China, primarily engaged in the development, manufacturing, and sale of a wide range of pharmaceutical products. The company operates in several sectors, including innovative drugs, generic drugs, bulk drugs, and nutritional and healthcare products. Its core products consist of cardiovascular drugs, anti-infective drugs, and central nervous system drugs. CSPC is recognized for its strong research and development capabilities, which enable it to consistently introduce new and effective pharmaceutical solutions to the market.

1093 Stock 12 Month Forecast

Average Price Target

HK$8.01

▼(-1.52%Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"HK$3","5":"HK$5","7":"HK$7","9":"HK$9","11":"HK$11"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.204722437,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$10.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.0067822198,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$8.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.0238633536,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$5.02</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,5,7,9,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.611,7.810517110538461,8.010034221076923,8.209551331615383,8.409068442153846,8.608585552692308,8.80810266323077,9.00761977376923,9.207136884307692,9.406653994846153,9.606171105384615,9.805688215923077,10.005205326461539,{"y":10.204722437,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.611,7.641444786138461,7.671889572276923,7.702334358415384,7.732779144553846,7.763223930692307,7.793668716830769,7.82411350296923,7.854558289107692,7.8850030752461535,7.9154478613846155,7.945892647523077,7.976337433661538,{"y":8.0067822198,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.611,7.411989488738461,7.212978977476923,7.013968466215385,6.814957954953846,6.615947443692308,6.416936932430769,6.217926421169231,6.018915909907692,5.819905398646155,5.620894887384615,5.421884376123078,5.222873864861539,{"y":5.0238633536,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.741,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.743,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.101,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.008,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.546,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.815,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.202,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.718,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.422,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.649,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.41,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.051,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.611,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >